Skip to main content
Articles & Publications , Thierry Van Nieuwenhove

How Quotient Sciences Is Using AI To Innovate and Meet The Growing Demand For Personalized Medicine

pharmaceuticalmanufacturer

In this article by Pharmaceutical Manufacturer, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses how the company is innovating to meet the growing demand for personalized medicine through AI, partnerships and meeting sustainability goals.

Thierry talks through what strategies Quotient Sciences is implementing to address supply chain challenges in a post-pandemic world and what roles do digital transformation and AI play in improving efficiency in your manufacturing processes.

Continue reading the full article on Pharmaceutical Manufacturer.

 

 

 

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, John McDermott Quotient Sciences’ John McDermott Contributes to Pharmaceutical Outsourcing Oral Solid Dosage Roundtable By: John McDermott
Read More
News & Announcements, Articles & Publications, John McDermott Q&A with Quotient Sciences’ John McDermott: Exploring the Benefits of Partnering with a CRDMO By: John McDermott
Read More
Get in touch
Humanity can't afford to wait, so neither can we.